Mirae Asset Global ETFs Holdings’s Nautilus Biotechnolgy NAUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$42.8K Buy
+22,898
New +$60.5K ﹤0.01% 3063
2025
Q2
– Sell
-29,126
Closed -$25.1K – 3159
2025
Q1
$25.1K Buy
29,126
+1,248
+4% +$1.85K ﹤0.01% 2959
2024
Q4
$46.8K Buy
27,878
+1,216
+5% +$2.91K ﹤0.01% 2916
2024
Q3
$76K Buy
26,662
+630
+2% +$1.63K ﹤0.01% 2811
2024
Q2
$60.9K Buy
+26,032
New +$68K ﹤0.01% 2738

Other funds holding NAUT

Mirae Asset Global ETFs Holdings's NAUT Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings opened a new position in Nautilus Biotechnolgy (NAUT) in Q2 2026: 22,898 shares worth $42.8K. The stake represents ﹤0.01% of the portfolio and ranks #3063 among its holdings. This is a return to the name: Mirae Asset Global ETFs Holdings previously reported a position in NAUT as recently as Q1 2025.

Mirae Asset Global ETFs Holdings first reported a position in NAUT in Q2 2024 and has held it in 5 quarters since. The position peaked at $76K in Q3 2024. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 22,898 shares of Nautilus Biotechnolgy worth $42.8K as of Q2 2026.
  • Nautilus Biotechnolgy was a new Mirae Asset Global ETFs Holdings position in Q2 2026.
  • Nautilus Biotechnolgy made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #3063 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Nautilus Biotechnolgy in Q2 2024 and has held it in 5 quarters since.
  • Mirae Asset Global ETFs Holdings's Nautilus Biotechnolgy position peaked at $76K in Q3 2024.
  • 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.